The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01658943
Brief Title: Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy (S1115)

First Submitted : August 3, 2012
First Submitted that Met QC Criteria : August 3, 2012
First Posted : August 7, 2012 (Estimate)

Results First Submitted : February 10, 2016
Results First Submitted that Met QC Criteria : February 10, 2016
Results First Posted : March 9, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : February 10, 2016
Last Update Posted : March 9, 2016 (Estimate)